treggraft
Trade name: Orca-T
Cell therapyexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04013685)
Timeline
Indications
Mechanism of action
- regulatory t cellsSupplementation
regulatory t cells supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07216443 | Phase 2 | Nov 30, 2025 | Orca Biosystems, Inc. |
| NCT06551584 | Phase 1 | Oct 31, 2024 | Orca Biosystems, Inc., Stanford University |
| NCT06195891 | Phase 1 | May 24, 2024 | City of Hope National Medical Center, National Cancer Institute (NCI) |
| NCT05316701 | Phase 3 | Jun 21, 2022 | Orca Biosystems, Inc. |
| NCT04013685 | Phase 1 | Sep 30, 2019 | Orca Biosystems, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Orca Biosystems, Inc. | For profit | 4 | 3 | 3 | 2019 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2024 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2024 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2024 |
4 organizations
Page 1 / 1